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Abstract
Ligands binding to Toll-like receptor (TLR), interleukin 1 receptor (IL-1R), or IFN-cR1 are known to trigger MyD88-mediated
signaling, which activates pro-inflammatory cytokine responses. Recently we reported that staphylococcal enterotoxins (SEA
or SEB), which bind to MHC class II molecules on APCs and cross link T cell receptors, activate MyD88- mediated pro-
inflammatory cytokine responses. We also reported that MyD88
2/2 mice were resistant to SE- induced toxic shock and had
reduced levels of serum cytokines. In this study, we investigated whether MHC class II- SE interaction by itself is sufficient to
activate MyD88 in MHC class II
+ cells and induce downstream pro-inflammatory signaling and production of cytokines such
as TNF-a and IL-1b. Here we report that human monocytes treated with SEA, SEB, or anti-MHC class II monoclonal
antibodies up regulated MyD88 expression, induced activation of NF-kB, and increased expression of IL-1R1 accessory
protein, TNF-a and IL-1b. MyD88 immunoprecipitated from cell extracts after SEB stimulation showed a greater proportion
of MyD88 phosphorylation compared to unstimulated cells indicating that MyD88 was a component of intracellular
signaling. MyD88 downstream proteins such as IRAK4 and TRAF6 were also up regulated in monocytes after SEB
stimulation. In addition to monocytes, primary B cells up regulated MyD88 in response to SEA or SEB stimulation.
Importantly, in contrast to primary B cells, MHC class II deficient T2 cells had no change of MyD88 after SEA or SEB
stimulation, whereas MHC class II-independent activation of MyD88 was elicited by CpG or LPS. Collectively, these results
demonstrate that MHC class II utilizes a MyD88-mediated signaling mechanism when in contact with ligands such as SEs to
induce pro-inflammatory cytokines.
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Introduction
In addition to their role as restricting elements in antigen
presentation, major histocompatibility complex (MHC) class II
molecules can trigger intracellular signals after ligand binding in
many cell types. Staphylococcal enterotoxins (SE), a group
of MHC class II binding proteins secreted by Staphylococcus aureus
[1–5], and monoclonal antibodies (mAb) against MHC-class II
molecules induce activation of tyrosine kinases, turnover of
membrane phosphoinositol, and expression of inflammatory
cytokine genes in monocytic cells [6–8]. Ligation of MHC class
II molecules in B cells also triggers intracellular Ca
2+ mobilization
and homotypic adhesion [9,10]. MHC class II dependent
induction of IL-1 gene expression and B-cell aggregation are
dependent on the activation of tyrosine kinases and protein
tyrosine kinase C [6,8,11,12]. Initiation of the principal signaling
pathway of MHC class II molecules in human B lymphocytes
requires the HLA-DRb cytoplasmic tail [13].
MyD88 is an essential anchor protein that integrates and
transduces intracellular signals generated by the Toll-like or IL-1
receptor (TLR or IL-1R) superfamily [14,15]. Whereas TLRs are
critical for detecting molecular patterns associated with microbial
pathogens [16–20], IL-1 receptor (IL-1R1) is important for
amplifying inflammatory responses triggered by microbial patho-
gens [21]. After ligand binding, dimeric MyD88 is recruited to the
membrane-receptor complexes through the interaction of its C-
terminal Toll-interleukin receptor (TIR) domain with an analo-
gous domain in the IL-1R or TLR receptors [16]. The N-terminal
death domain of MyD88 recruits the death domain-containing IL-
1R-associated kinases (IRAKs) [14]. Activation of IRAK leads to a
downstream signaling cascade that activates NF-kB, p38 mitogen-
activated protein kinase (MAPK), and other factors, ultimately
inducing production of inflammatory cytokines. Although TIR
domain-linked interaction is important for MyD88-mediated
signaling, MyD88 also interacts with interferon gamma receptor
1 (IFNGR1), which lacks a TIR domain [22]. This latter
interaction enhances expression of pro-inflammatory cytokines in
response to IFN-c stimulation. Similar interactions have been
detected between MyD88 and other proteins lacking TIR and
death domains such as Bruton’s tyrosine kinase [23], phosphatidyl-
inositol-3-OH kinase [24], and interferon regulatory factor 7
(IRF7) [25]. These reports indicate that MyD88 can associate with
signaling proteins by means other than homophilic TIR or death-
domain interactions. We also found that MyD88
2/2 mice were
resistant to SE intoxication and had impaired pro-inflammatory
cytokine responses [26,27]. These results lead us to suggest that
MHC class II molecules, which serve as signal-transducing
receptors [28–30], may also utilize the cytosolic adaptor protein
MyD88 for implementation of downstream signaling. We
investigated the role of MyD88 signaling following MHC class II
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present direct evidence that engagement of MHC class II by SEB,
SEA, or by anti-MHC class II antibodies in human primary
monocytes and B cells, results in increased MyD88 signaling, NF-
kB activation and cytokine responses.
Materials and Methods
Reagents
Staphylococcal enterotoxin B (SEB) and Staphylococcal entero-
toxin A (SEA) were purchased from Porton Down, Inc. (Salisbury,
UK), and was prepared under GMP condition, endotoxin free and
stored at 250uC. Escherichia coli LPS (055:B5) was purchased from
Difco laboratories (Detroit, MI.). Pooled human AB sera were
obtained from Pel-Freez (Brown Deer, WI). A cytometric bead
array kit for cytokines was purchased from BD Biosciences
Pharmingen (San Diego, CA). RNA-extracting reagent Tri-
Reagent was obtained from Molecular Research Center, Inc.
(Cincinnati, OH), and Maloney murine leukemia virus reverse
transcriptase was purchased from Perkin Elmer (Waltham, MA).
Mouse anti-human CD14 and CD3 mAbs conjugated with
magnetic beads were obtained from Miltenyi Biotech Inc.
(Auburn, CA). The FITC-conjugated mAbs anti-CD14, anti-
CD3, and Ig isotype control antibodies were purchased from BD
Biosciences (San Jose, CA). Primary anti-MyD88 antibody was
obtained from AnaSpec, Inc. (San Jose, CA) and Alexis
Biochemicals (San Diego, CA). Anti- b-actin antibody was
purchased from Imgenex (San Diego, CA) and Cell Signaling
Technology (Danvers, MA). The mAb LB3.1 (anti-HLA-DRa) has
been previously described [31] and was produced in ascites fluid.
Purified OKT3 mAb was obtained from e-Bioscience (San Diego,
CA). The mouse anti-human HLA-class II DP-DQ-DR mAb
(MCA477), which recognizes HLA class II b chain of human
MHC antigen, was obtained from Serotec, Ltd. (Oxford, UK).
Goat anti-rabbit IgG (PE-labeled) was purchased from Pierce
(Rockford, IL). Monoclonal anti-glyceraldehyde -3-phospahate
dehydrogenase (GAPDH)-conjugated to horseradish peroxidase
was purchased from Sigma Chemical Co. (St. Louis, MO).
Maloney murine leukemia virus reverse transcriptase was
purchased from Perkin Elmer (Waltham, MA). Agarose-bound
anti-human MyD88 antibody was purchased from Santa Cruz
Biotechnology (San Diego, CA). Anti-phosphotyrosine antibody
and anti-IRAK-1 antibody was purchased from Cell Signaling
Technology (Danvers, MA). Cell permeabilizing buffer was
purchased from BD Biosciences Pharmingen (San Diego, CA).
MHC class II antigen negative T2 cells (B cell line) were obtained
from ATCC (Manasass, VA, USA). CpG-NT 10103 type B CpG
oligonucleotide specifically optimized for vaccine applications was
kindly provided by Chad Roy (USAMRIID) and has been
described elsewhere [32]. Anti-TRAF6 antibody was purchased
from Epitomics, Inc. (Burlingame, CA) and anti-IRAK4 antibody
was purchased from MBL International (Woburn, MA).
Human cell isolation from blood and culture
Peripheral blood mononuclear cells were obtained from healthy
donors with written consents, in accordance with guidelines of the
human use committee (HUC) and institutional (USAMRIID)
review board-approved research donor protocol FY 05-05.
Mononuclear cells were isolated by standard density gradient
centrifugation with Ficoll-Hypaque (GE Healthcare Biosciences
AB, Uppsala, Sweden), harvested from the interface, washed, and
suspended in RPMI 1640 medium. Monocytes (CD14
+) were
purified as previously described [33]. Briefly, total mononuclear
cells were suspended (10
7cells/80 ml) in cold PBS supplemented
with 2 mM EDTA and 0.5% bovine serum albumin (BSA)
(Fraction V; Sigma Chemical Co., St. Louis, MO). Paramagnetic
beads coated with anti-CD3 mAbs (Miltenyi Biotech) were mixed
with the mononuclear cells (10
7cells/20 ml). The antibody-bound
cells were incubated for 15 min (4uC), washed, and passed through
a type LS or RS iron-fiber column placed within a strong magnetic
field (Miltenyi Biotech). CD3
+ T-cells bound to the column were
eluted with buffer after withdrawal from the magnetic field.
Monocytes were isolated from cells not bound to the anti-CD3
column, by repeating the process above with anti-CD14 mAb-
coated beads. Cell purities were .98% as determined by flow
cytometry analyses of isolated mononuclear cell subsets used in all
reported experiments.
Cytokine assays
Cell cultures were incubated (37uC, 5% CO2) for 16 h.
Supernatants were collected, and cells harvested for measuring
transcriptional activation of the MyD88 gene and intracellular
expression of MyD88 protein. Cytokines in culture supernatants
were measured by a cytometric bead array kit (BD Biosciences
Pharmingen) using capture beads coated with antibodies specific
for cytokines. Flow cytometry analysis was done according to the
manufacturer’s method, as described elsewhere [32].
NF-kB assays
We used ELISA-based chemiluminescence Trans AM Chemi
Kit (Active Motif, Carlsbad, CA) and antibodies to detect NF-kB
recognition of epitope on p50 and p65, according to the
manufacturer’s protocol. Assays were performed in triplicate to
measure NF-kB by using equal amounts of protein from the cell
extracts.
RT-PCR
Total RNA was extracted from untreated and treated human
monocytes, using Tri-Reagent (Molecular Research Center Inc,).
The mRNA was reverse transcribed into cDNA with Maloney
murine leukemia virus reverse transcriptase, according to the
manufacturer’s instructions. Amplification was performed with
gene-specific primers, MyD88 (Forward 59-CACTCGCAGTT-
TGTTGGATG-39; Reverse 59-CGCAGGATACTGGGAAAG-
TC-39), and b-actin (Forward 59- TCCTGTGGCATCCACGA-
AACT-39; Reverse 59-GAAGCATTTGCGGTGGACGAT-39),
TNF-a (Forward 59- CGG GAC GTG GAG CTG GCC GAG G-
AG-39; Reverse 59-CAC CAG CTG GTT ATC TCT CAG CT-
C-39); IL-1b (Forward 59- AAA CAG ATG AAG TGC TCC TT-
C GAG G-39; Reverse 59- TGG AGA ACA CCA CTT GTT GC-
T CCA-39). Human sIL-1RACP (Forward 59-GATGGATTC-
TCGCAATGAGG-39; Reverse 59-ACTATGGGTTAGATGC-
GTC-39);
Human mIL-1RACP (Forward 59-GATGGATTCTCGCAAT-
GAGG-39;
Reverse 59-TGAGAATCACCACTAGCAGG-39); Human
HLA-DR (Forward 59-GCTATCAAAGAAGAACATGTG-39;
Reverse 59-GAGCGCTTTGTCATATTTCCAG-39). PCR prod-
ucts were separated by electrophoresis on a 1.5% agarose gel,
stained with ethidium bromide, and photographed as previously
described [34].
Real-time PCR analysis
Semi-quantitative real time PCR was performed using cDNA
collected as described above. Amplification was performed using
4 mlo fa1mM final concentration of gene specific primers as
described before, 10 ml of Power Sybr Green PCR master mix,
MHC Class II-Linked Activation of MyD88 Signaling
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Finally, the 20 ml PCR reaction was amplified using a 7900HT
Fast Real Time PCR System. The final normalized results were
calculated by dividing the relative transcript levels of the test genes
by the relative amount of the b-actin RNA.
Western blot analysis
Human monocytes (CD14
+), B cells (CD19
+) or U937 cells were
cultured in a 24-well plate at 2 24610
6 cells/ml. These cells
rested for 2 hrs in a 37uC incubator. Cells were treated with LPS
at 1 mg/ml, SEB at 200 ng/ml, SEA at 200 ng/ml or left
untreated for the indicated times. Cells were collected into fresh
1.5 ml centrifuge tubes and chilled on ice for 5 minutes before
centrifuging. Membrane and cytoplasm separation was done by
suspending the pellets in 50 ml of lysis buffer (Active Motif) in the
presence of DTT, protease inhibitors and phosphatase inhibitors
and incubated on ice for 30–60 minutes. Membrane fraction was
collected by centrifuging the lysates at 140006g for 20 minutes.
Supernatant contained the cytoplasmic fraction and pellet
contained membrane fraction. Samples containing 10 mg of total
cytoplasmic proteins were separated by gel electrophoresis and
transferred to nitrocellulose membranes. Membranes were
blocked overnight in Tris-buffered saline containing 0.1% Tween
20 and 3% BSA at 4uC. Blots were extensively washed and probed
with anti-MyD88 polyclonal antibody followed by HRP-conju-
gated secondary Ab. Blots were washed extensively and developed
with chemiluminescent substrate in the presence of hydrogen
peroxide using Immun-Star WesternC Chemiluminescent Kit
(BioRad). An imaging system VersaDoc Model 4000 (BioRad) was
used to capture the image.
Co-immunoprecipitations
Monocytes were cultured in a 24-well plate at 224610
6 cells/
ml of media and rested for 2 hrs in a 37uC incubator. Cells
were treated with SEB at 200 ng/ml or left untreated for the
indicated times. Cells were collected into fresh 1.5 ml centrifuge
tubes and chilled on ice for 5 minutes before centrifuging. Wells
were washed twice more with cold PBS. Cells were then
resuspended in 1 ml of lysis buffer (50 mM Tris-HCl, 150 mM
NaCl, 1% NP-40, pH 8.0), left on ice for 40 to 60 minutes and
passed twice through a 26-gauge syringe. After lysing, samples
were rotated overnight at 4uC in the presence of agarose-bound
anti-human MyD88 Ab (Santa Cruz Biotechnology). After
washing three times in cold PBS, the agarose pellets were
resuspended in no more than 40 ml of loading buffer (5% b-
mercaptoethanol) and boiled for 5 min. 20 ml per sample were
separated by electrophoresis, transferred to nitrocellulose mem-
branes and blocked overnight at 4uC and probed with a mouse
anti-phosphotyrosine antibody. Blots were washed extensively and
developed with chemiluminescent substrate in the presence of
hydrogen peroxide using Immun-Star WesternC Chemilumines-
cent Kit (BioRad). An imaging system VersaDoc Model 4000
(BioRad) was used to capture the image.
Intracellular staining and confocal microscopy
Freshly isolated monocytes (CD14
+) adhered to sterile culture
slides (Corning Glass, Corning, NY) were incubated with either
SEA, SEB (200 ng/ml), mAb to anti-DP-DQ-DR, LB3.1, or
OKT3 in RPMI 1640 medium. B cells or T2 cells were incubated
with either CpG (10 mg/ml) or LPS 1 mg/ml in eppendorf tubes.
Cells were gently washed with PBS (pH 7.4, 37uC) and then fixed
with 1% paraformaldehyde (Tousimis Research, Rockville, MD)
plus 0.1% glutaraldehyde (Sigma-Aldrich) in PBS (5 min, 20uC).
The fixed cells were washed with PBS containing 0.5% bovine
serum albumin (BSA) and incubated (30 min, 20uC) in a
permeabilization solution (Becton Dickinson). Cells were then
washed and incubated (15 min, 20uC) with PBS containing 5%
BSA to block non-specific antibody binding. Cells were incubated
with primary HLA-DR and MyD88 antibody for 1 h, washed in
PBS, containing 0.5% BSA, then incubated with Alexa 488-
conjugated goat anti-mouse secondary antibody and Alexa 568-
conjugated goat anti-rabbit secondary antibody. Cells
were counterstained with DAPI to detect cell nuclei. Labeled B
and T2 cells were mounted on glass slides using fluoromount and
covered with glass coverslips. Labeled cells were imaged using a
BioRad (Hemel Hempstead, UK) Radiance 2000 MP laser
scanning confocal system connected to a Nikon (Melville, NY)
TE 300 inverted microscope. Green and red fluorescence
were visualized using 488-nm and 568 nm wavelength excitation
respectively from a krypton/argon laser, and DAPI images
were collected using a two-photon excitation from a Ti/sapphire
laser tuned to 800 nm. Images were collected using BioRad
LaserSharp software. Images taken for the purpose of comparing
control antibody-treated to MHC ligand-stimulated cells were
collected using identical settings, and any subsequent processing of
the images was likewise performed identically for the two
conditions.
Flow cytometry
To examine cell-surface expression of proteins on purified
monocytes, cells were incubated (20 min, 4uC) with FcR-blocking
reagent (Miltenyi Biotech) and washed twice with Hank’s balanced
salt solution (HBSS) containing 0.1% BSA. Cells were then
incubated with FITC-labeled anti-CD14, anti-CD3 mAb, or
isotype-matched control antibody. Unbound antibody was re-
moved by washing the cells with HBSS (4uC) and centrifugation.
After two additional washes, the labeled cells were fixed with 1%
paraformaldehyde in PBS, and the cell-associated immunofluo-
rescence was measured by flow cytometry (FACSCaliber, Becton
Dickinson, San Jose, CA). Intracellular expression of MyD88
protein in CD14
+ monocytes was examined using a modified
method similar to intracellular staining of phosphorylated proteins
in lymphocytes (BD Biosciences). Briefly, after treatment either
with SEA, SEB, mAbs, or LPS, CD14
+ monocytes were pelleted,
washed once with PBS, and immediately fixed by mixing one
volume of cells to 20 volumes of 16Phosphoflow Lyse/Fix buffer
(BD Pharmingen, San Diego, CA). Cells were incubated (10 min,
37uC), pelleted and permeabilized with PhosFlow Perm Buffer (III)
(BD Pharmingen) for 30 min on ice, washed twice with BD
Pharmingen TM stain buffer and pelleted by centrifugation (3006
g) for 5 min. Cells were suspended (10
7/ml) in BD Pharmingen
stain buffer. BD FcR-block antibody (0.06 mg) was added for each
10
7 cells, which were incubated on ice for 15 min. Cells were
labeled with primary anti-MyD88 antibody (rabbit polyclonal) or
isotype-matched control antibody followed by secondary goat anti-
rabbit 568 (Molecular Probe). The labeled cells were washed,
suspended in stain buffer and MyD88 expression was measured by
flow cytometry.
Statistical analysis
The SAS program version 9.2 (Cary, North Carolina) was used
for statistical analysis. Repeated measures ANOVA were used for
statistical analysis and pair wise comparisons of untreated vs
treatment were used for real time PCR assays. Statistical
significant differences between groups and control were deter-
mined by Student’s T- test. Significant differences are indicated by
asterisks and p values reported in figure legends.
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MyD88, IL-1R1, and TNF-a are up regulated in monocytes
by engagement of HLA class II molecules
MHC class II molecules on APCs act as signaling receptors for
ligands such as SEB, SEA, or mAbs directed against MHC class II
molecules. The binding of these specific ligands to MHC class II
molecules induces pro-inflammatory responses including release of
TNF-a and IL-1b. In the event of superantigen induced toxicity, it
is known that SE binds to MHC Class II molecules on APCs and
Vb-containing T cell receptors, activating APCs and T cells and
inducing pro-inflammatory cytokine production. We explored the
possibility that induction of TNF-a and IL-1b by direct MHC
class II- binding of SE in monocytes might be due to MyD88
activation. We treated human primary CD14
+ monocytes (98%
pure) with SEB, LB3.1 (mAb that recognizes an epitope on DR-a
of HLA molecules), or anti-DR-DQ-DP (mAb directed against the
DR-bchain of the HLA-DR molecule which also recognizes
epitopes on HLA-DP and -DQ) for 2 h. MyD88, interleukin-1
receptor accessory protein (IL-1R1AcP), and TNF-a mRNA were
all substantially induced at 2 h (Figure 1A) as detected by RT-
PCR. Similar data were collected at 16 h (data not shown). In
contrast, the control mAb (OKT3) did not activate the cells
(Figure 1A). The IL-1R1AcP acts as a co-receptor for IL-1R1 and
is an indispensable molecule in the IL-1R1 signal transduction
complex [34]. Induction of the membrane-bound form of IL-
1R1AcP by SEB (Figure 1A) is particularly worthy of note because
it is an essential component of the trimeric IL-1/IL-1 receptor/
mIL-1RAcP complex necessary for downstream MyD88 signaling
[35]. To confirm the RT-PCR results, we used real time PCR for
accurate and reproducible measurement of MyD88 mRNA levels
in monocytes stimulated with SEA, SEB, LPS, OKT3 and anti-
DR-DP-DQ. The real time PCR analysis confirmed that, similar
to LPS activation, monocytes treated with MHC class II ligands
such as SEA, SEB, and anti-DR-DP-DQ significantly increased
transcription of MyD88 compared to unstimulated monocytes or
control antibody (OKT3) (Figure 1B). Importantly, prior treat-
ment of monocytes with anti-DR-DP-DQ antibody in ice followed
by SEB stimulation significantly reduced transcription of MyD88
(data not shown) as well as TNF-a gene (Figure 1C) as detected by
real time PCR indicating that SEB acts through HLA and not
other surface components. In addition to transcriptional activation
of MyD88 in primary monocytes, confocal microscopy and flow
cytometry analysis indicated a substantial increase in intracellular
expression of MyD88 protein levels following treatment with SEB,
SEA, or LB3.1 or anti-DR-DP-DQ compared to the control
antibody OKT3 (Figure 1D and E). Although direct interaction of
HLA-DR and MyD88 cannot be determined from confocal
images, the partial overlap of fluorescence observed in the images,
particularly with anti-DR-DP-DQ mAb-treated cells, is consistent
with this possibility. Results shown in Figure 1D indicate HLA-DR
ligands initiated up regulation of MyD88 protein above the levels
of the controls. Flow cytometry analysis using an isotype matched
control antibody did not show up regulation of MyD88 (data not
shown). In Figure 1E the FACS showed along with anti-DR-DP-
DQ, SEA or SEB treatment increased up regulation of MyD88.
The effect was greater with SEA or SEB. Collectively, results
shown in Figure 1A-E suggest that engagement of MHC class II
molecules either by SEA, SEB or anti-MHC class II antibody up
regulated MyD88. It is important to note that these data were
from primary monocytes isolated from different donors. The level
of up regulation appeared to have some normal donor –to- donor
variation. In addition to RT-PCR and real time PCR, confocal
and FACS analysis were used to confirm these results at a single
cell level (Figure 1D) as well as multiple cell level (Figure 1E). The
results in Figure 1 consistently suggest that engagement of MHC
class II molecules by SEA, SEB or anti-MHC class II antibody up
regulated MyD88.
SEB stimulation of monocytes along with up regulation
of MyD88, activates NF-kB and cytokines
To further validate our observation that intracellular MyD88
synthesis is consistently up regulated in a vast majority of the
monocytes as a consequence of SEB stimulation, a more detailed
analyses of the effects of SEB binding was examined by comparing
a large number of untreated vs SEB treated monocytes following 1
and 4 h of treatment using microscopy. Results shown in Figure 2A
indicate that, compare to untreated cells, MyD88 was strongly up
regulated 1 and 4 h after SEB stimulation in monocytes.
Activation of NF-kB p50 and p65 was also seen in monocytes
after SEB stimulation (Figure 2B). Next we examined whether
SEB- induced up- regulation of MyD88 in monocytes is
physiologically relevant and consistent in the presence of T cells.
For this, we examined up regulation of IL-1b and TNF-a in
purified monocytes that were separated from the total mononu-
clear cell population stimulated with SEB and from total
unstimulated mononuclear cells (Unt). Our results showed that,
consistent with up regulation of MyD88 protein, IL-1b and TNF-a
expression were up regulated either with SEB as well as SEA
treatment compared to untreated controls (Figure 2C). Taken
together, these results suggest that MHC class II based recognition
of SEA or SEB in monocytes alone or within a total mononuclear
cell population induces MyD88 up regulation and downstream
signaling via NF-kB, potentially enabling pro-inflammatory
cytokine response. MyD88 up regulation was also observed in T
cells (data not shown).
De novo synthesis, homodimerization and
phosphorylation of MyD88 after SEB stimulation of
monocytes
Recruitment of MyD88 dimer to the receptor-membrane
complex is a requirement for MyD88- mediated signaling and
activation of the down-stream kinases IRAK1 and IRAK4 [36].
MyD88 exists as a homodimer with a molecular mass of approx.
62–66 kDa but could also be detected as a monomer with a
molecular mass of 31–33 kDa in SDS-PAGE [37]. To further
substantiate that SEB binding to MHC class II molecules activates
MyD88, we stimulated primary monocytes with SEB. Western
blot analysis showed up regulation of MyD88 in SEB treated
monocytes compared to untreated cells, consistent with confocal
microscopy and flow cytometry results. An increase in MyD88, as
two bands of an approximate molecular mass of 62–66 kDa
(homodimer) and 31–33 kDa (monomer) was observed in
activated cells while b- actin levels remained the same
(Figure 3A). Protein expression bands in the Western blots were
quantified band intensities and compared untreated vs SEB
activated monocytes using 10 mg and 20 mg protein of cytoplasmic
fractions (Figure S1). These results are consistent with an earlier
report where in vivo MyD88 expression was observed as a dimer
(62–66 kDa) as well as a monomer (31 kDa) using SDS-PAGE/
Western analysis [37]. To our knowledge, this is the first report
which suggests that primary monocytes after SEB stimulation up
regulated MyD88, exhibited as a dimer as well as monomer. A
similar observation was made in monocytes collected from
multiple donors (Figure S2). However, the levels of up regulation
of the dimer varied from donor to donor which is not unexpected.
Furthermore, probing with phosphotyrosine antibody, a 25 kDa
MHC Class II-Linked Activation of MyD88 Signaling
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PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e15985Figure 1. Ligand engagement of HLA class II molecules up regulates MyD88, IL-1R1, and TNF-a in CD14
+ human monocytes treated
with SEB, SEA, or mAb directed against MHC-class II molecules. (A) Transcriptional activation of MyD88, IL-1R1AcP and TNF-a in HLA-DR
positive primary monocytes treated with 200 ng SEB/ml (optimum dose), mAbs (10 mg/ml, optimum dose) directed against MHC-class II molecule
(anti-DR-DP-DQ or LB3.1) or unrelated control antibody OKT3 was examined by semi-quantitative RT-PCR. Data shown is one of 3 similar experiments;
(B) Agonists binding to TLR4 or HLA class II molecules on CD14
+ monocytes induced transcriptional up regulation of MyD88. Real time RT-PCR was
used to determine relative expression of MyD88 normalized to the expression of b-actin. Expression levels are determined as means +/2 SD. Data
presented as one of 3 similar experiments. Significance compared to untreated control (*) was assigned as P#0.0001. (C) MHC class II molecule
dependence of SEB- induced TNF- a gene expression. Pretreatment of monocytes in ice with anti-DR-DP-DQ at optimum dose (10 mg/ml) followed by
SEB stimulation resulted in reduced TNF- a gene expression. Transcriptional activation of TNF- a expression normalized to the expression of b-actin.
Expression levels of TNF- a are expressed as means +/2 SD. Significance was assigned (*) or (**) as P values #0.003 comparing untreated vs treatment
groups with anti-DR-DP-DQ, SEB or SEB vs anti-DR-DP-DQ+SEB respectively. (D) Confocal images show expression of HLA-DR (green) and intracellular
MyD88 (red) proteins in CD14
+ monocytes treated with HLA class II- ligands or control antibody OKT3 for 16 h; Scale bar =5 mm; (E) intracellular
expression of MyD88 protein in activated monocytes. Primary monocytes (CD14
+, CD3
-) were activated as described earlier, permeabilized and
labeled with primary MyD88 antibody followed by PE-labeled secondary antibody and analyzed by flow cytometry. Histogram represents a MHC class
II ligand-induced increase in expression of MyD88 protein compared to non-MHC class II ligand (OKT3).
doi:10.1371/journal.pone.0015985.g001
Figure 2. SEB stimulation of monocytes activates MyD88, NF-kB, TNF-a, and IL-1b. SEB engagement of HLA-class II on human monocytes
induced intracellular up regulation of MyD88, TNF-a, and IL-1b compared to untreated control and additionally activated NF-kB. (A) Confocal images
show intracellular up regulation of MyD88 protein in primary monocytes stimulated with SEB for 1 h compared to untreated monocytes; Scale
bar=10 mm. (B) Activation of NF-kB in primary monocytes treated with SEB. Data are presented in the figure as percentage increase over the
untreated control and represent one of three experiments using separate donors. Significance was assigned as follows; p50 (p=0.009) and p65
(p=0.004). (C) Transcriptional activation of IL-1b, and TNF-a mRNA was measured by real time RT-PCR in isolated primary monocytes after stimulation
of total mononuclear cells with SEA or SEB.
doi:10.1371/journal.pone.0015985.g002
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band was not prominent in cytosolic fractions in Western Blot
analysis when probed with MyD88 antibody raised to the C-
terminal 233–248 aa region, suggesting that the 25 kDa protein
may likely be a degraded MyD88 (Figure 3A). To further confirm
phosphorylation of MyD88 after SEB stimulation, we performed
immunoprecipitation of whole cell lysates by anti-MyD88
antibody raised against full length MyD88 protein (1–296 aa),
and probed with phosphotyrosine antibody in Western blot
analysis. The 62 kDa protein was recognized when probed with
anti-MyD88 antibody (Figure 3C). However, the 62 kDa protein
was barely detectable with anti-phosphotyrosine antibody whereas
the 25 kDa band showed very strongly in immunoprecipitated
extracts (Figure 3D), suggesting that the 25 kDa band is possibly
degraded after phosphorylation of MyD88. It has been previously
reported that phosphorylation of signaling adaptor Mal is required
for Mal to signal [38]. A very recent report indicated that in
macrophage TLR signaling SyK interacted with and induced
tyrosine phosphorylation of MyD88, which led to degradation of
these adaptor molecules by the E3 ubiquitin ligase Cbl-b [39]. Also
PYK2, a major cell adhesion-activated tyrosine kinase interacts
with MyD88 and appeared to be tyrosine phosphorylated upon
coexpression of PYK2 and regulates MyD88-mediated NF-kB
activation in macrophages [40]. In this study, our results suggest
that SEB stimulation of monocytes induced phosphorylation of
MyD88. A strong 25 kDa band was detected after immunopre-
cipitation with anti- MyD88 antibody followed by probing with
phosphotyrosine antibody which suggests that MyD88 undergo
phosphorylation, polyubiquitination and degradation. Taken
together, these results suggest that engagement of HLA molecules
by SEB allowed de novo synthesis and phosphorylation of MyD88.
Up regulation of IRAK4, IRAK1 and TRAF6 after SEB
stimulation of primary monocytes and U937 cells
The functional activation of MyD88-mediated pro-inflamma-
tory signaling is enabled through engagement of the MyD88-
downstream signaling components such as IRAK1, IRAK4 as well
as TRAF6. To validate that SEB stimulation activated MyD88-
mediated signaling, we treated primary monocytes and monocytic
cell line U937 with SEB and examined IRAK4, IRAK1 and
TRAF6 along with MyD88 in Western blot analysis. Results
shown in Figure 4 indicate that in addition to MyD88,
downstream signaling components such as IRAK4 and TRAF6
were also up regulated. We further confirmed these results in
monocytes from different donors that showed up regulation of
IRAK1 by striping the blot and rebloting with anti-MyD88
antibody and b-actin (Figure S3). Taken together, these results
suggest that engagement of HLA-DR molecules with SEB enabled
Figure 3. SEB stimulation induced de novo synthesis and phosphorylation of MyD88. CD14
+ cells were treated with SEB for different times
or left untreated as indicated. Cells were lysed, membrane fraction and cytoplasm fraction were isolated by centrifugation. Cytoplasmic fractions were
run by electrophoresis and blotted using an anti-human MyD88 antibody. (A) Up regulation of MyD88 (62 kDa) dimer and 31 kDa monomer after SEB
stimulation. Monocytes were treated with SEB (200 ng/ml) for 1 h or left untreated. (B) Phosphotyrosine antibody recognized MyD88 (25 kDa) band
in cytoplasmic extracts of monocytes stimulated with SEB. (C) MyD88 protein up regulation in monocytes after SEB stimulation. Monocytes (CD14
+)
were treated with SEB (200 ng/ml) for 30 min or 2 h or left untreated. After treatments, cytoplasmic fractions were isolated, separated by
electrophoresis and probed with anti-MyD88 or anti-b-actin antibody. (D) SEB stimulation of monocytes induced phosphorylation of MyD88. Part of
the cytoplasmic fractions isolated after SEB stimulation as described in (C) was immune-precipitated with an agarose-bound anti-human MyD88,
separated by electrophoresis and blotted against an anti-phosphotyrosine antibody (a-PY).
doi:10.1371/journal.pone.0015985.g003
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activation of downstream signaling components.
MHC class II-linked up regulation of MyD88 in primary B
cells
Ligation of MHC class II molecules in B cells can trigger
intracellular signaling via the activation of tyrosine kinases and
protein tyrosine kinase C [6,8,11,12]. TLR engagement by LPS or
CpG is also known to be involved in pro-inflammatory signaling
via MyD88 in B cells. To characterize MHC class II- linked up
regulation of MyD88 in cells other than monocytes, we examined
MHC class II positive primary B cells (CD19
+, MHC class II
+)
after SEB stimulation. Confocal microscopy results showed that,
compared to untreated cells, intracellular MyD88 was up
regulated in primary B cells when stimulated with SEB as well
as with LPS or CpG (Figure 5). These results suggest that similar to
LPS or CpG, SEB up regulated MyD88 in B cells.
B cells but not MHC class II- deficient B-cells, respond to
SEB and up regulate MyD88
To confirm MHC class II-linked activation of MyD88 in B cells,
we compared the effects of SEA or SEB stimulation on MyD88
levels in primary B cells and MHC class II negative T2 cells. Our
results demonstrated that SEA or SEB stimulation of primary B
cells up regulated MyD88 dimer whereas MHC class II negative
T2 cells did not (Figure 6A). However, non-MHC class II-linked B
cell ligands such as CpG or TLR-dependent LPS did activate
MyD88 in T2 cells (Figure 6B). These results suggest that SEB
induces up regulation of MyD88 dependent to MHC class II
receptor in primary B cells.
Discussion
In this study, our results show that engagement of HLA -class II
molecules by either mAbs or the superantigens SEB and SEA up
regulated MyD88 and increased expression of IL-1R1, IL-1b, and
TNF-a. This MHC class II-linked up regulation of MyD88 after
SEA or SEB stimulation and pro-inflammatory cytokine expres-
sion was observed in purified monocytes as well as in primary B
cells, but not in MHC class II deficient B cells. Furthermore,
MyD88 activation was associated with de novo synthesis and
phosphorylation of MyD88. Importantly, our results also suggest
that along with MyD88, SEB stimulation induced up regulation of
other downstream signaling components such as IRAK4 and
TRAF6. Typically, activation of TLR/IL-1R –MyD88-mediated
signaling initiates with the recruitment of MyD88 to the receptor
complexes. MyD88 primarily functions because its TIR domain
heterodimerizes with the receptor and homodimerizes with
another MyD88 molecule to recruit downstream signaling
molecules. This includes the IRAK1-4 kinases via MyD88’s death
domain that ultimately results in activation of NF-kB and the
expression of inflammatory cytokines such as TNF-a, IL-1b and
IL-6.
However, a recent report indicated that IFN-c stimulation of
macrophages resulted in physical association of MyD88 with IFN-
cR1, which naturally lacks the TIR domain [22]. Our recent
results indicated that MyD88-mediated pro-inflammatory signal-
ing is critical to SEA or SEB induced toxicity. SEs bind to MHC
class II on APCs and to T- cell receptors, activating both cell types
and inducing pro-inflammatory responses. In this study, our data
suggest that MHC class II receptor-SE interaction up regulates
MyD88, IRAK4, TRAF6, NF-kB and cytokine expression in
monocytes.
Although the precise role of MHC class II molecules in signal
transduction remains unclear, overwhelming evidence indicates
that MHC class II molecules serve as signaling proteins in diverse
antigen-presenting cells such as B cells, dendritic cells, and
monocytes. HLA-DR-specific antibodies and SEB, which bind
directly to MHC class II molecules, induce IL-1 production in
human monocytes and myeloid cell lines [6,7]. Thus, MHC class
II molecules serve as signaling proteins in diverse antigen-
presenting cells. Anti-MHC class II antibodies induce early
biochemical signals, like a rise in cyclic AMP accompanied by
nuclear translocation of protein kinase C in murine B cells [41].
Figure 4. SEB stimulation induced up regulation of IRAK4 and TRAF6 in primary monocytes and U937 cells. Primary monocytes or
human monocytic cell line U937 were treated with SEB or left untreated as indicated. Cells were lysed, membrane fraction and cytoplasm fraction
were isolated by centrifugation. Cytoplasmic fractions were run by electrophoresis and blotted using an anti-human MyD88 antibody or anti-IRAK4,
or anti-TRAF6 antibody. (A) Up regulation of MyD88 (62 kDa) dimer and 31 kDa monomer, TRAF6, IRAK4 after SEB stimulation in monocytes (B) Up
regulation of MyD88 (62 kDa) dimer and 31 kDa monomer, TRAF6, IRAK4 after SEB stimulation in U937 cells.
doi:10.1371/journal.pone.0015985.g004
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tion of inositol phosphates, increases intracellular calcium
concentrations, and enhances tyrosine phophorylation in human
B cells [9,10]. Thus, ligands that engage MHC class II molecules
trigger intracellular signaling in human monocytes, monocytic cell
lines, and B cells through tyrosine phosphorylation of cellular
proteins by activated protein kinase C and protein tyrosine kinases
[7,8]. However, besides the involvement of protein tyrosine kinase
induction of inflammatory cytokines in response to SEB, other
plausible mechanisms for intracellular signaling have not been
described in the literature. Hence, SEA or SEB induced activation
of MyD88 and the subsequent pro-inflammatory signaling has not
been previously characterized. Ours is the first demonstration of
MyD88 up regulation following MHC class II –SE interaction in
monocytes and in B cells but not in MHC class II negative cells. A
recent report [42] indicated that in B cells MyD88 is required for
the production of natural antibodies, which is impaired in
MyD88
B2/2 chimeric mice due to a lack of B cell signaling via
MyD88.
The pro-inflammatory cytokines TNF-a and IFN-c use
signaling pathways that involve Janus kinases and signal
transducers and activators of transcription (STATs) [43]. Howev-
er, MyD88 has no known function in these pathways. Earlier
studies showed that both PTK and PKC play essential roles in
HLA-class II molecule-mediated signal transduction induced by
SEB and suggested the possibility that SEB induced IL-1b and
TNF-a gene expression are differently regulated by distinct
additional regulatory pathways [8,44]. In this study, our results
uncover a key process of MHC class II receptor signaling through
recruitment of MyD88. Further, no increase of TNF-a by MHC
class II positive cells from MyD88 knockout mice were observed
after SEA stimulation suggests the existence of a MHC class II-
linked MyD88-mediated signaling mechanism [26]. These data
provide a novel concept that signaling via the MyD88 pathway is
not limited to the TLR/IL-1R, but rather is generally shared by
other receptors such as MHC receptors. Previous reports indicated
that intra-cytoplasmic domains of MHC class II molecules and
lipid-rich microdomains play a key role in MHC class II-mediated
signaling [45]. It was also reported that CD38 and HLA-DR are
functionally and physically associated in lipid raft microdomains at
the cell surface of monocytes. Tetraspanin CD9 molecules and
lipid raft microdomains are necessary for HLA-DR and CD38
signaling events [46]. Although the underlying mechanism by
which MHC class II recruits MyD88 needs further investigation,
as the adaptor protein is known to integrate signals through TIR
domain-TIR domain interactions [16]. Recently it was reported
after LPS or peptidoglycan stimulation of macrophages required
MyD88 for PYK2 induced NF-kB activation and MyD88
appeared to be tyrosine-phosphorylated [40]. To our knowledge,
this report provides the first evidence that MHC class II molecules,
which serve as signaling receptors despite the absence of a TIR
domain, recruit cytosolic MyD88 for inflammation. Importantly,
our data also demonstrates MyD88-mediated amplification of pro-
inflammatory cytokines upon SEB binding to MHC class II
molecules on monocytes, even in the absence of T-cells. In a
related study, we also observed significant up regulation of
intracellular MyD88 in CD11c positive cells and macrophages
isolated from the spleens of mice inoculated with SEB [27]. Our
study describes MHC class II linked activation of MyD88-
mediated pro-inflammatory signaling among isolated monocytes,
as well as in human mixed PBMC cultures stimulated with SEB or
SEA. These results suggest that SEA or SEB binding to MHC class
II molecules to CD14
+ monocytes leads to MyD88 activation and
pro-inflammatory signaling. The biological effect of SEB is
thought to result in cross-linking of T-cell receptors and MHC
class II in the absence of conventional antigen processing. It has
also been reported that [47] MHC class II-peptide-specific T cells
responded to ova peptide in a MyD88- dependent manner.
Figure 5. MHC class II-linked up regulation of MyD88 in primary B cells. Primary B cells (CD19
+) were cultured in the presence of SEB
(200 ng/ml), CpG (10 mg/ml), or LPS (1 mg/ml), fixed, permeabilized and labeled with anti-human MyD88 antibody. Confocal images show intracellular
up regulation of MyD88 protein in primary monocytes stimulated with SEB, LPS or CpG compared to untreated cells; Scale bar =5 mm.
doi:10.1371/journal.pone.0015985.g005
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2/2 mice failed to elicit Th1 cytokine response to ova
peptide. Thus, a linkage of MHC class II and MyD88 in antibody
[42] and T cell response is beginning to emerge.
MyD88 is a required component for promoting productive T
cell-independent (TI) B cell receptor (BCR) signaling where
Bruton’s tyrosine kinase (BTK, a cytoplasmic kinase that lacks
TIR domain but is crucial for BCR-mediated activation)
participates in a TI antibody response [48]. The most striking
result of this earlier study was that while the absence of BTK and
MyD88 entirely abrogated Borrelia hermsii Ag-specific IgM
antibody production, it remained relatively robust in the absence
of BTK alone. Thus, without BTK and normal BCR signaling, B.
Figure 6. B cells but not MHC class II deficient T2 cells respond to SEB and activate MyD88. B cells or T2 cells were treated with SEA
(200 ng/ml) or SEB (200 ng/ml) or kept untreated. Cells were lysed, membrane fraction and cytoplasm fraction were isolated by centrifugation.
Cytoplasmic fractions were run by electrophoresis and blotted using an anti-human MyD88 antibody. (A) Detection of MyD88 after SEA and SEB
stimulation in B cells or T2 cells. (B) Intracellular up regulation of MyD88 (red) in T2 cells after CpG and LPS stimulation; Scale bar =10 mm.
doi:10.1371/journal.pone.0015985.g006
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presumably by stimulating other signaling pathways [48]. It is
an intriguing possibility that the MHC class II –MyD88 mediated
signaling described in our current study could also be involved in
an alternative functional pathway for antibody responses.
Although the current study did not investigate the role of proteins
that are likely associated with MHC class II in the activation of
MyD88–mediated signaling, their involvement nonetheless re-
mains a distinct possibility. Further investigation of the MHC class
II–MyD88 interaction will elucidate not only the molecular
mechanism underlying MHC class II-MyD88-mediated activation
of inflammatory responses, but also the in vivo significance.
Supporting Information
Figure S1 SEB stimulation up regulated MyD88 com-
pared to untreated monocytes. (A) Up regulation of MyD88
after SEB stimulation. (B) Quantification of MyD88 protein
expression (62kDa) in cytoplasmic fractions (20 mg and 10 mg) from
untreated and SEB treated monocytes compared to b-actin
expression in Western blot analysis.
(TIF)
Figure S2 MyD88 up-regulation after SEB stimulation
of monocytes isolated from three independent donors.
Monocytes were treated with SEB (200 ng/ml) for 1h or left
untreated. Cells were lysed, membrane fraction and cytoplasm
fraction were isolated by centrifugation. Cytoplasmic fractions
were run by electrophoresis and blotted using an anti-human
MyD88 antibody and anti-GAPDH antibody was used as control.
(TIF)
Figure S3 SEB stimulation up regulated IRAK1 and
MyD88 as compared to untreated monocytes. Monocytes
were treated with SEB (200 ng/ml) for 1h or left untreated. Cells
were lysed, membrane fraction and cytoplasm fraction were
isolated by centrifugation. Cytoplasmic fractions were run by
electrophoresis and blotted using an anti-IRAK1 antibody, blot
was sequentially striped and reprobed with anti-human MyD88
antibody, and b-actin.
(TIF)
Acknowledgments
The authors thank Sarah Norris for statistical analysis, Lorraine Farinick
for figure preparation, and Dr. Bradley Stiles for critical review of the
manuscript. The views in this paper are those of the authors and do not
purport to reflect official policy of the U.S. Government.
Author Contributions
Conceived and designed the experiments: KUS. Performed the experi-
ments: TLK GR SA SF. Analyzed the data: KUS SF RGU. Contributed
reagents/materials/analysis tools: GR SF. Wrote the paper: KUS TLK SF.
References
1. Mollick JA, Cook RG, Rich RR (1989) Class II MHC molecules are specific
receptors for staphylococcus enterotoxin A. Science 244: 817–820.
2. Fraser JD (1989) High-affinity binding of staphylococcal enterotoxins A and B to
HLA-DR. Nature 339: 221–223.
3. Fischer H, Dohlsten M, Lindvall M, Sjogren HO, Carlsson R (1989) Binding of
staphylococcal enterotoxin A to HLA-DR on B cell lines. J Immunol 142:
3151–3157.
4. Scholl P, Diez A, Mourad W, Parsonnet J, Geha RS, et al. (1989) Toxic shock
syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Proc Natl Acad Sci U S A 86: 4210–4214.
5. Ulrich RG, Bavari S, Olson MA (1995) Bacterial superantigens in human
disease: structure, function and diversity. Trends Microbiol 3: 463–468.
6. Trede NS, Geha RS, Chatila T (1991) Transcriptional activation of IL-1 beta
and tumor necrosis factor-alpha genes by MHC class II ligands. J Immunol 146:
2310–2315.
7. Palkama T, Sihvola M, Hurme M (1989) Induction of interleukin 1 alpha (IL-1
alpha) and IL-1 beta mRNA expression and cellular IL-1 production by anti-
HLA-DR antibodies in human monocytes. Scand J Immunol 29: 609–615.
8. Palkama T, Hurme M (1993) Signal transduction mechanisms of HLA-DR-
mediated interleukin-1 beta production in human monocytes. Role of protein
kinase C and tyrosine kinase activation. Hum Immunol 36: 259–267.
9. Lane PJ, McConnell FM, Schieven GL, Clark EA, Ledbetter JA (1990) The role
of class II molecules in human B cell activation. Association with phosphatidyl
inositol turnover, protein tyrosine phosphorylation, and proliferation. J Immunol
144: 3684–3692.
10. Mooney NA, Grillot-Courvalin C, Hivroz C, Ju LY, Charron D (1990) Early
biochemical events after MHC class II-mediated signaling on human B
lymphocytes. J Immunol 145: 2070–2076.
11. Mourad W, Geha RS, Chatila T (1990) Engagement of major histocompatibility
complex class II molecules induces sustained, lymphocyte function-associated
molecule 1-dependent cell adhesion. J Exp Med 172: 1513–1516.
12. Cambier JC, Morrison DC, Chien MM, Lehmann KR (1991) Modeling of T
cell contact-dependent B cell activation. IL-4 and antigen receptor ligation
primes quiescent B cells to mobilize calcium in response to Ia cross-linking.
J Immunol 146: 2075–2082.
13. Rich T, Lawler SE, Lord JM, Blancheteau VM, Charron DJ, et al. (1997) HLA
class II-induced translocation of PKC alpha and PKC beta II isoforms is
abrogated following truncation of DR beta cytoplasmic domains. J Immunol
159: 3792–3798.
14. Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:
499–511.
15. O’Neill LA (2003) The role of MyD88-like adapters in Toll-like receptor signal
transduction. Biochem Soc Trans 31: 643–647.
16. Akira S (2003) Toll-like receptor signaling. J Biol Chem 278: 38105–8.
17. Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:
335–376.
18. Beutler B (2004) Inferences, questions and possibilities in Toll-like receptor
signalling. Nature 430: 257–263.
19. Barton GM, Medzhitov R (2003) Toll-like receptor signaling pathways. Science
300: 1524–1525.
20. Takeda K, Akira S (2004) TLR signaling pathways. Semin Immunol 16: 3–9.
21. Graves DT, Chen CP, Douville C, Jiang Y (2000) Interleukin-1 receptor
signaling rather than that of tumor necrosis factor is critical in protecting the host
from the severe consequences of a polymicrobe anaerobic infection. Infect
Immun 68: 4746–4751.
22. Sun D, Ding A (2006) MyD88-mediated stabilization of interferon-gamma-
induced cytokine and chemokine mRNA. Nat Immunol 7: 375–381.
23. Jefferies CA, Doyle S, Brunner C, Dunne A, Brint E, et al. (2003) Bruton’s
tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that
participates in nuclear factor kappaB activation by Toll-like receptor 4. J Biol
Chem 278: 26258–26264.
24. Ojaniemi M, Glumoff V, Harju K, Liljeroos M, Vuori K, et al. (2003)
Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated
cytokine expression in mouse macrophages. Eur J Immunol 33: 597–605.
25. Honda K, Yanai H, Mizutani T, Negishi H, Shimada N, et al. (2004) Role
of a transductional-transcriptional processor complex involving MyD88 and
IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 101:
15416–15421.
26. Kissner TL, Cisney ED, Ulrich RG, Fernandez S, Saikh, KU (2010)
Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and
lethality in mice is primarily dependent on MyD88. Immunology 130: 516–526.
27. Kissner TL, Ruthel G, Cisney ED, Ulrich RG, Fernandez S, et al. (2010)
MyD88-Dependent pro-inflammatory cytokine response contributes to lethal
toxicity of staphylococcal enterotoxin B in mice. Innate Immunity (in press).
28. Hauschildt S, Bessler WG, Scheipers P (1993) Engagement of major
histocompatibility complex class II molecules leads to nitrite production in
bone marrow-derived macrophages. Eur J Immunol 23: 2988–2992.
29. Spertini F, Chatila T, Geha RS (1992) Signals delivered via MHC class II
molecules synergize with signals delivered via TCR/CD3 to cause proliferation
and cytokine gene expression in T cells. J Immunol 149: 65–70.
30. Faassen AE, Pierce SK (1995) Cross-linking cell surface class II molecules
stimulates Ig-mediated B cell antigen processing. J Immunol 155: 1737–1745.
31. Gorga JC, Knudsen PJ, Foran JA, Strominger JL, Burakoff SJ (1986)
Immunochemically purified DR antigens in liposomes stimulate xenogeneic
cytolytic T cells in secondary in vitro cultures. Cell Immunol 103: 160–173.
32. Saikh KU, Kissner TL, Sultana A, Ruthel G, Ulrich RG (2004) Human
monocytes infected with Yersinia pestis express cell surface TLR9 and
differentiate into dendritic cells. J Immunol 173: 7426–7434.
33. Saikh KU, Khan AS, Kissner T, Ulrich RG (2001) IL-15-induced conversion of
monocytes to mature dendritic cells. Clin Exp Immunol 126: 447–455.
34. Saikh KU, Lee JS, Kissner TL, Dyas B, Ulrich RG (2003) Toll-like receptor and
cytokine expression patterns of CD56+ T cells are similar to natural killer cells in
MHC Class II-Linked Activation of MyD88 Signaling
PLoS ONE | www.plosone.org 11 January 2011 | Volume 6 | Issue 1 | e15985response to infection with Venezuelan equine encephalitis virus replicons. J Infect
Dis 188: 1562–1570.
35. Wesche H, Korherr C, Kracht M, Falk W, Resch K, et al. (1997) The
interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced
activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated
protein kinases (SAP kinases). J Biol Chem 272: 7727–7731.
36. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, et al. (2002) Severe
impairment of interleukin-1 and Toll-like receptor signalling in mice lacking
IRAK-4. Nature 416: 750–756.
37. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, et al. (1998) MyD88, an
adapter protein involved in interleukin-1 signaling. J Biol Chem 273:
12203–12209.
38. Gray P, Dunne A, Brikos C, Jefferies CA, Doyle SL, et al. (2006) MyD88
adapter-like (Mal) is phosphorylated by Bruton’s tyrosine kinase during TLR2
and TLR4 signal transduction. J Biol Chem 281: 10489–10495.
39. ChaofengHan, Jin J, Xu S, Liu H, NanLi, et al. (2010) Integrin CD11b
negatively regulates TLR-triggered inflammatory responses by activating syK
and promoting degradation of MyD88 and TRIF via Cbl-b. Nature Immunol
11: 734–743.
40. Xi CX, Xiong F, Zhou Z, Mei L, Xiong WC (2010) PYK2 interacts with
MyD88 and regulates MyD88-mediated NF-kappaB activation in macrophages.
J Leukoc Biol 87: 415–423.
41. Cambier JC, Newell MK, Justement LB, McGuire JC, Leach KL, et al. (1987) Ia
binding ligands and cAMP stimulate nuclear translocation of PKC in B
lymphocytes. Nature 327: 629–632.
42. Barr TA, Brown S, Mastroeni P, Gray D (2009) B cell intrinsic MyD88 signals
drive IFN-gamma production from T cells and control switching to IgG2c.
J Immunol 183: 1005–1012.
43. Darnell JE, Jr., Kerr IM, Stark GR (1994) Jak-STAT pathways and
transcriptional activation in response to IFNs and other extracellular signaling
proteins. Science 264: 1415–1421.
44. Matsuyama S, Koide Y, Yoshida TO (1993) HLA class II molecule-mediated
signal transduction mechanism responsible for the expression of interleukin-1
beta and tumor necrosis factor-alpha genes induced by a staphylococcal
superantigen. Eur J Immunol 23: 3194–3202.
45. Becart S, Setterblad N, Ostrand-Rosenberg S, Ono SJ, Charron D, et al. (2003)
Intracytoplasmic domains of MHC class II molecules are essential for lipid-raft-
dependent signaling. J Cell Sci 116: 2565–2575.
46. Zilber MT, Setterblad N, Vasselon T, Doliger C, Charron D, et al. (2005) MHC
class II/CD38/CD9: a lipid-raft-dependent signaling complex in human
monocytes. Blood 106: 3074–3081.
47. Buatois V, Baillet M, Becart S, Mooney N, Leserman L, et al. (2003) MHC class
II-peptide complexes in dendritic cell lipid microdomains initiate the CD4 Th1
phenotype. J Immunol 171: 5812–5819.
48. Alugupalli KR, Akira S, Lien E, Leong JM (2007) MyD88- and Bruton’s tyrosine
kinase-mediated signals are essential for T cell-independent pathogen-specific
IgM responses. J Immunol 178: 3740–3749.
MHC Class II-Linked Activation of MyD88 Signaling
PLoS ONE | www.plosone.org 12 January 2011 | Volume 6 | Issue 1 | e15985